biguanides has been researched along with Brain Neoplasms in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roh, TH | 1 |
| Lee, JH | 1 |
| Kim, SJ | 1 |
| Shim, JK | 1 |
| Park, J | 1 |
| Yoon, SJ | 1 |
| Teo, WY | 1 |
| Kim, SH | 1 |
| Chang, JH | 1 |
| Kang, SG | 1 |
1 other study available for biguanides and Brain Neoplasms
| Article | Year |
|---|---|
A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres.
Topics: Adenosine Triphosphate; Animals; Biguanides; Brain Neoplasms; Cell Line, Tumor; Energy Metabolism; G | 2022 |